#Generic Drugs

India poised for weight-loss drug price war as semaglutide patent expires

Patent expiry sets stage for generic competition India's pharmaceutical market is bracing for a seismic shift as the patent on semaglutide-the active ingredient in Novo Nordisk's blockbuster weig...